McGuireWoods Consulting President L.F. Payne and Executive Vice President and Chairman-elect Mark Bowles were recently tapped to serve on Virginia Governor-elect Ralph Northam’s Transition Committee. Mark has also been named a co-chair of the Inaugural Committee.
McGuireWoods’ Board of Partners has elected Jonathan P. Harmon to succeed Richard Cullen as McGuireWoods’ chairman. In addition, the board appointed J. Tracy Walker IV to follow Thomas E. Cabaniss as the firm’s managing partner.
McGuireWoods Consulting senior vice president and law firm partner Mike Reynold was quoted in an Oct. 27 Wall Street Journal story about this year’s race for governor in Virginia.
Jim Hodges, a former South Carolina governor who heads McGuireWoods Consulting’s national multistate team and is a partner with the McGuireWoods law firm, appeared alongside Virginia Gov. Terry McAuliffe at a University of Chicago Institute of Politics forum.
McGuireWoods Romania announced today that three new consultants have joined its Bucharest office.
In recent years, state emissions credit programs and policy have sought to incentivize only renewable electricity generation, leaving out other sources of zero-emissions generation.
This Week: House and Senate Work to Avoid Government Shutdown; Legislation on Gag Clauses Moving; Oral Arguments on ACA Individual Mandate Court Case Held
Your weekly North Carolina political news report.
This week: Senate Commerce Committee advances science and technology policy nominees, House and Senate Committees question social media executives, net neutrality still controversial, House Panel discusses apprenticeship expansion
This week: House Committee to look at emerging transportation technologies, congress intensifying its response to robocalls and California passes initial revisions to new privacy law.
An overview of the upcoming week in Congress from the McGuireWoods Consulting Federal Public Affairs Team.
The Centers for Medicare and Medicaid Services (CMS) recently proposed to expand its site-neutral payment policy to clinic visits.
The House of Representatives approved the first major change to federal regulation of the over-the-counter drug industry in 40 years.